The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
4549316 5712427 I 4549316-9 20040613 20040617 20041230 PER 04-06-0874 IVAX PHARMACEUTICALS, INC. 63 YR F N 20040907 MD

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
4549316 1005569643 PS CLOZAPINE 1 ORAL 450MG QD ORAL Y D 74949

Indications of drugs used

Event ID DRUG SEQ INDI PT
4549316 1005569643 SCHIZOPHRENIA, PARANOID TYPE

Outcome of event

Event ID OUTC COD
4549316 LT
4549316 OT
4549316 RI

Reactions reported

Event ID PT
4549316 AGRANULOCYTOSIS
4549316 URINARY TRACT INFECTION

Reporting Sources (this data is often not reported and may therefore be missing here)

Event ID RPSR COD
4549316 HP
4549316 OTH

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
4549316 1005569643 20031001 20040601